Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Capsulin oral insulin adjunct study in type 1 diabetes
ACTRN12622000764730Phase 3Completed
- Sponsor
- Child and Adolescent Health Service
- Start
- Apr 2023
- Modality
- Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of Capsulin in diabetes mellitus type 1 (T1D), sponsored by Child and Adolescent Health Service. Primary endpoint: Composite insulin dosing outcome. Started Apr 2023; status: completed.
02
Drugs
Capsulin
03
Conditions
diabetes mellitus type 1 (T1D)
Beyond the preview
Go deeper on ACTRN12622000764730.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12622000764730.